Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil in obese insulin-resistant adults
NCT02819440Phase 2Completed
- Sponsor
- Vanderbilt University Medical Center
- Start
- Jul 2016
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tadalafil in obesity, prediabetes, sponsored by Vanderbilt University Medical Center. Started Jul 2016; status: completed.
02
Drugs
tadalafil
03
Conditions
obesityprediabetes
Beyond the preview
Go deeper on NCT02819440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02819440.